Unicycive Therapeutics Inc (NASDAQ:UNCY) shares, rose in value, with the stock price down by -3.55% to the previous day’s close as strong demand from buyers drove the stock to $0.59.
Actively observing the price movement in the recent trading, the stock is buoying the session at $0.61. Referring to stock’s 52-week performance, its high was $0.96, and the low was $0.20. On the whole, UNCY has fluctuated by -8.51% over the past month.
With the market capitalization of Unicycive Therapeutics Inc currently standing at about $71.07 million, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that UNCY’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of UNCY currently trading nearly -1.06% and -1.24% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.49, while the 7-day volatility ratio is showing 4.37% which for the 30-day chart, stands at 5.20%. Furthermore, Unicycive Therapeutics Inc (UNCY)’s beta value is 2.03, and its average true range (ATR) is 0.05.
A comparison of Unicycive Therapeutics Inc (UNCY) with its peers suggests the former has fared considerably weaker in the market. UNCY showed an intraday change of -3.55% in today’s session so far, and over the past year, it shrunk by -37.71%%.
Data on historical trading for Unicycive Therapeutics Inc (NASDAQ:UNCY) indicates that the trading volumes over the past 3 months, they’ve averaged 886.99K. According to company’s latest data on outstanding shares, there are 119.75 million shares outstanding.
Nearly 17.08% of Unicycive Therapeutics Inc’s shares belong to company insiders and institutional investors own 50.74% of the company’s shares. The stock has fallen by -25.81% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the UNCY stock heading into the next quarter.
